Q: Kindly give us your take on the just released TFII Q1 results and forward prospects. Thank you very much.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Last week DND held a Virtual Investor Day which I missed. Were there any highlights concerning the company's plans going forward or was it mostly housekeeping material?
Thanks
Dave
Thanks
Dave
Q: I was interested in Jeff's follow-up comment on Excelon sales declining. Who sold it before Knight in Latam and Canada? Perhaps the reason the company made a deal with Knight is to improve visibility and awareness while giving Knight's sales force new avenues for it's other products.
The price tag does not appear to be a bargain (Knight paid $360M or double for $250M sales in Biotoscan). Surely Goodman sees value in this deal. If there was no effort before then potential must be factored in and I suspect Latam is the more coveted marketplace. Can you comment and provide any previous history with sales of this product. Alzheimers us unfortunately, not going anywhere soon.
The price tag does not appear to be a bargain (Knight paid $360M or double for $250M sales in Biotoscan). Surely Goodman sees value in this deal. If there was no effort before then potential must be factored in and I suspect Latam is the more coveted marketplace. Can you comment and provide any previous history with sales of this product. Alzheimers us unfortunately, not going anywhere soon.
Q: Hi Team,
Could you comment on SHOP? it hasn't gone anywhere since last July.... Is this about market sentiment? no more momentum? Should I get out???
Thanks!
Could you comment on SHOP? it hasn't gone anywhere since last July.... Is this about market sentiment? no more momentum? Should I get out???
Thanks!
Q: Interesting that Well Health has shot up 8% this morning. Was there any news? Could there be a potential short squeeze occurring?
Q: Just a further comment to James' question and your answer regarding the Exelon purchase. This purchase left me scratching my head. I am a healthcare provider who works in the area where Exelon would be used. I don't see much Exelon used. As you indicated, it is a mature product. However, revenues have been declining over several years, at least according to Macrotrends (available at https://www.macrotrends.net/stocks/charts/EXC/exelon/revenue) so I don't know what rabbit GUD can pull out to wring increased revenues from this medication.
Q: Great article on Csu and its founder Leonard by Andrew Willis, Apr26 Globe and Mail Report on Business
Q: Hello,
Interested in your answer earlier this morning that you believe WELL at $5.75 is attractive and what you based that value on? This concerning to me as many questions have been asked of your team top picks as to where to deploy new money over the past months and WELL was more often than not included in the answer. At these points WELL was trading between $7-$9 range. So fundamentally, what has changed?
Interested in your answer earlier this morning that you believe WELL at $5.75 is attractive and what you based that value on? This concerning to me as many questions have been asked of your team top picks as to where to deploy new money over the past months and WELL was more often than not included in the answer. At these points WELL was trading between $7-$9 range. So fundamentally, what has changed?
Q: Do you believe Magna is a buy at today's price?
Q: Thanks for your great services. Earlier during Covid, I put in an order for well at $4.20, but only 10% of the order was filled. I've watched my tiny position do well over the last 6 months - wishing I had a larger position, LOL. I guess it's anyone's guess how low the stock could go - perhaps you can comment on that. Can you recommend an entry price for a bargain hunter?
Q: Hello,
In a follow up to my prior question. Can you please give your specific take with respect to the specific issues outlined in the short report. I am aware that it may require some research so please feel free to take your time in response to this question.
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
In a follow up to my prior question. Can you please give your specific take with respect to the specific issues outlined in the short report. I am aware that it may require some research so please feel free to take your time in response to this question.
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
Q: a lot of discussions today on why WELL is so bad, yet today TD upgraded stock price from $10 to $10.50 ... is this simply showing symbolic support based on their DD, or am I reading to much into this upgrade
Q: WELL is sinking like a rock based on this short report. Grizzlyreports.com/we-believe-well-health-technologies-is-a-toxic-roll-up
What are you thoughts on the issues:
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
- etc
What are you thoughts on the issues:
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
- etc
Q: Breaking News on BNN a few mins ago that there was a Short seller on Well .Please comment. Current price $6.70 -0.30 on1.6m shares exceeding 943k(3 mos average)
Q: Further to your comments today about Superior, could you also provide the payout percentage and if you consider it a buy today as a new position. This would be more for income than growth. A couple other questions: where does most of their propane go - residential or commercial? How does propane fit into the current "green" initiatives relative to other hydrocarbons?
Thank-you
Thank-you
Q: Hello 5i,
What is your take on the Knight Theraputics deal and thoughts on the stock in general? Is it a buy here?
What is your take on the Knight Theraputics deal and thoughts on the stock in general? Is it a buy here?
Q: There is currently a lot of selling pressure with this stock. Is there a way to tell it could be a short attack and do you think it is.
Q: Hi, Do u think Sylogist can keep moving upwards with the recent momentum after not doing a whole lot for several years, thanks?
Q: Since its last financing @ $9.80(all paid by billionarie Mr K.S.Li & his rich friends),CRH has declined to current $7(near its other $6.75 financing partially funded by Mr Li) Have a 3.5% position,p/p $8.37.Add or hold.Please comment.Txs for u usual great views & services
Q: hi guys i was wondering if you could explain in layman terms what is the reason for recent volatility .I realize they are selling debt but how does that facilitate shorting the stock